| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536967 | Vaccine | 2017 | 8 Pages |
Abstract
During the European 2016/17 influenza season, A(H3N2) viruses have predominated and the majority clustered in genetic subclade 3C.2a1. Genetic analyses showed that circulating viruses have undergone considerable genetic diversification of the haemagglutinin gene from the current vaccine virus A/Hong Kong/4801/2014 (clade 3C.2a), but the antigenic data that is limited by the challenges with the antigenic characterisation of currently circulating A(H3N2) viruses, showed no clear evidence of antigenic change. The recommended A(H3N2) vaccine component for the northern hemisphere 2017/18 influenza season remained unchanged. However, early and mid-season vaccine effectiveness (VE) estimates were suggestive of reduced VE against A(H3N2) viruses.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Angeliki Melidou, Eeva Broberg, European region influenza surveillance network European region influenza surveillance network,